Search results
Pfizer-Connect Biopharma deal for inflammatory drug ends
Seeking Alpha· 12 hours agoConnect Biopharma (CNTB) terminates licensing deal with Pfizer (PFE) for CBP-174, an oral...
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
FierceBiotech· 18 hours agoPfizer’s cost cuts that began last year have stretched to the closure of a well-known internal R&D...
Canaan hires Pfizer executive, reels in $100M for biotech investing
BioPharma Dive via Yahoo Finance· 19 hours agoThe firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist...
Pfizer Inc. (NYSE:PFE) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 2 days agoVontobel Holding Ltd. lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 27.0% in the fourth quarter, according to the company in its most recent filing ...
Harel Insurance Investments & Financial Services Ltd. Sells 21,260 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoHarel Insurance Investments & Financial Services Ltd. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 28.6% during the 4th quarter, according to its ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 5 days ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact
FierceBiotech· 18 hours agoConnect Biopharma is uncoupling from Pfizer, returning the rights to an eczema candidate it picked...
VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science
FierceBiotech· 18 hours agoGeneral Partner Julie Grant told Fierce Biotech that the money will act as a designated pool for...
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25...
Investing.com· 7 days agoNEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the...
New Insider Trading Precedent: Time To Update Insider Trading Policy | JD Supra
JD Supra· 12 hours agoThe SEC’s complaint alleged that Panuwat used highly confidential information of his employer, Medivation, Inc.’s (“Medivation”) upcoming acquisition by Pfizer Inc. (“< ...